Ensign Peak Advisors, Inc - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ensign Peak Advisors, Inc ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,765,616
+41.9%
232,614
+31.0%
0.02%
+47.1%
Q2 2023$8,292,798
+23.5%
177,614
+1.2%
0.02%
+13.3%
Q1 2023$6,717,079
-24.9%
175,564
+7.5%
0.02%
-25.0%
Q4 2022$8,946,867
+54.5%
163,264
-4.0%
0.02%
+42.9%
Q3 2022$5,790,000
+756.5%
170,034
+137.8%
0.01%
+600.0%
Q2 2022$676,000
+88.3%
71,491
+182.7%
0.00%
+100.0%
Q1 2022$359,000
-32.9%
25,2850.0%0.00%0.0%
Q4 2021$535,000
-5.3%
25,2850.0%0.00%0.0%
Q3 2021$565,000
-10.0%
25,2850.0%0.00%0.0%
Q2 2021$628,000
-14.3%
25,2850.0%0.00%
-50.0%
Q1 2021$733,000
+12.4%
25,2850.0%0.00%
+100.0%
Q4 2020$652,000
+9.6%
25,285
+30.9%
0.00%
-50.0%
Q3 2020$595,000
-12.2%
19,321
-29.0%
0.00%0.0%
Q2 2020$678,000
+109.3%
27,202
+78.2%
0.00%
+100.0%
Q1 2020$324,000
-38.8%
15,269
-35.9%
0.00%0.0%
Q4 2019$529,00023,8230.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$179,29657.03%
Redmile Group, LLC 2,632,912$144,283,5785.90%
Avidity Partners Management LP 3,825,000$209,610,0004.54%
COMMODORE CAPITAL LP 537,076$29,4324.44%
Atlas Venture Life Science Advisors, LLC 594,251$32,564,9553.92%
Paradigm Biocapital Advisors LP 604,544$33,129,0113.89%
Yiheng Capital Management, L.P. 1,468,905$80,495,9943.56%
Altium Capital Management LP 125,000$6,850,0003.48%
Tri Locum Partners LP 128,851$7,061,0002.86%
SILVERARC CAPITAL MANAGEMENT, LLC 172,100$9,431,0802.70%
View complete list of AKERO THERAPEUTICS INC shareholders